Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Encephalopathy
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 23, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Harriet C Isom1, Emily I McDevitt, Mi Sun Moon
1Department of Microbiology and Immunology, The Pennsylvania State College of Medicine, Hershey, PA 17033, USA. hisom@psu.edu
Iron overload in the liver, linked to hereditary hemochromatosis and hepatitis C virus (HCV) infection, causes cellular damage and altered growth. Further research is needed to understand these complex molecular changes in the liver.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: